Products and Services
Comprehensive Tumour Profiling (MI Profile)
Caris Life Sciences®
Caris MI Profile™ is a comprehensive tumour profiling platform designed to guide precision oncology. Through advanced whole exome sequencing (WES), whole transcriptome sequencing (WTS), and protein analysis, Caris MI Profile™…
cResponse™ Future of Cancer Therapy Selection
Curesponse
cResponse™ is an ex vivo functional platform that assess and predicts the effectiveness of single and multidrug chemotherapy, immunotherapy as well as innovative biological treatments on the tumour tissue.
Tumour Biopsy Molecular Profiling (MI Tumor Seek)
Caris Life Sciences®
MI Tumor Seek™ is a Next-Generation Sequencing (NGS)-based tumour profiling service that includes Whole Exome Sequencing (WES) analysis of DNA for mutations, copy number alterations*, insertions/deletions, genomic signatures (MSI, TMB*,…
Caris Assure®: Blood based tumour profiling
Caris Life Sciences®
Introduction Caris Assure® is blood based comprehensive molecular profiling designed for patients with previously diagnosed solid tumours when tissue biopsy is not feasible. It combines whole-exome sequencing (WES) of cell-free…
TC100 – Combined Blood Testing for Testicular Germ Cell Tumours
TC100 combines miR-371a-3p (M371) with classical serum markers to support diagnosis and follow-up of testicular germ cell tumours. Available via EDX Medical.
Prostate cancer ‘super test’
EDX Medical scientists working in Oxford and Cambridge have developed a new ‘super test’ for prostate cancer. The involves blood and urine samples which are analysed using the most comprehensive…
BC95 – Advanced Bowel Cancer Testing Service
BC95 is an advanced bowel cancer testing service combining complementary screening and genetic assessment tools to support clinical decision-making and referral pathways.
EarlyTect ® Stool DNA Test for Colorectal Cancer Screening
A stool-based molecular screening test that detects methylated SDC2 DNA associated with colorectal cancer. Supports non-invasive early detection and risk assessment.
Hereditary Cancer Testing – Multi-Gene Germline Panel
A comprehensive NGS test that identifies inherited variants in cancer-predisposition genes. It supports the diagnosis of hereditary cancer syndromes and informs risk assessment, surveillance, and family testing.
qFit – Quantitative Faecal Immunochemical Test
A stool-based screening test that detects human haemoglobin in faeces. Used to support colorectal cancer screening and identify patients who may require further investigation.
ARDP (Acute Respiratory Distress & Pneumonia) ICU test
EDX Medical is working in collaboration with Cambridge University, Addenbrooke’s Hospital, Cambridge, and the UK Health Security Agency (UKHSA) on the development of a new assay for early, definitive detection…
Read MoreAvailable SoonMultiple biomarker 5FU pharmacogenomic test
EDX Medical is developing, in collaboration with the University of Oxford, a new benchmark test for all patients receiving fluoropyrimidine-based chemotherapies.
Point of care multiplex sepsis test
EDX is launching a breakthrough, highly sensitive 20-minute bedside test that can detect the presence or absence of bacteria or viral infections and help guide the selection of the most…
Laboratory Services
PCR testing
A polymerase chain reaction (PCR) test is used to identify the genetic material of a particular organism, such as a virus. When used for COVID-19, a PCR test helps determine…
